Infinium Pharmachem Ltd

NSE: INFINIUM · Other · sector

₹284.55NSE close 2026-10-26

Key numbers

Market cap₹443 cr

Price₹284.55

52w high / low₹324 / ₹189

P/E36.5xSector median 14.4x

P/B4.2xSector median 1.7x

Book value₹67.7

Dividend yield–Sector median 0.37%

ROE12.2%Sector median 13.8%

ROCE19.6%Sector median 19.6%

OPM11.4%Sector median 10.4%

Debt / equity–Sector median 0.29x

EV/EBITDA19.2xSector median 8.4x

Interest cover7.4x

Current ratio3.84x

Sales growth 3y–Sector median +7.7%

Profit growth 3y–Sector median +16.6%

PEG–

Last 12 months to Mar 2026, Consolidated. "Sector median" = middle value of 688 companies in Other (P/E median leaves out loss-making companies). Tap ? for what a number means.

Things to know

Operating profit covered interest 7.4x in the last 12 months.
Other income was 18% of net profit in the last 12 months.
No dividend in the last 2 financial years.
Price ₹284.55 on 2026-10-26: -12.3% from the 52-week high, +50.2% from the 52-week low.

Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.

Charts

Weekly close · high ₹352.80 · low ₹199.95

Quarterly results

₹ cr	Sep 2023	Sep 2024	Mar 2025	Sep 2025	Mar 2026
Revenue	61	83	73	84	106
EBITDA	10	8	8	10	11
OPM %	16.7%	10.2%	10.9%	12.4%	10.5%
Other income	0	1	1	1	1
Net profit	6	5	4	6	7
EPS (₹)	4.46	3.17	2.57	3.59	4.20
Revenue YoY					+71.7%
Profit YoY					+4.3%

Consolidated figures where filed. Latest quarter Mar 2026.

Profit & loss (yearly)

₹ cr	FY25	FY26	TTM
Revenue	156	190	190
EBITDA	16	22	22
Net profit	8	12	12
EPS (₹)	5.60	7.80	7.80
Revenue growth		+21.8%	–
Profit growth		+49.1%	–
Dividend / share (₹)	–	–

Compounded growth	3 years	5 years	Last 12 months
Sales	–	–	–
Net profit	–	–	–
EPS	–	–	–
Share price	–	-2.0% (2y)	+16.5%

Balance sheet

₹ cr	FY25	FY26
Shareholders' equity	94	105
Cash & equivalents	35	30
Total assets	198	175
Fixed assets	21	20
Investments	29	29
Inventory	44	39

Year-end figures from the March annual filing.

Cash flow

₹ cr	FY25	FY26
Cash from operations	-29	34
Cash from investing	-27	-7
Cash from financing	79	-32
Capex	9	10
Free cash flow	-38	24

Free cash flow = cash from operations − capex.

Ratios by year

₹ cr	FY25	FY26
ROE %	8.7%	11.5%
ROCE %	16.2%	19.6%
Inventory days	137	96
Working capital days	179	157

Peers in Other

Company	Market cap	P/E	P/B	ROE	ROCE	OPM	Sales 3y	Div yield
TSFINV	₹8,585 cr	17.6x	1.4x	8.4%	3.6%	20.5%	+121.7%	2.30%
KRISHANA	₹6,339 cr	39.9x	11.3x	41.6%	23.2%	12.6%	+95.7%	0.05%
MARINE	₹5,431 cr	84.2x	11.0x	14.3%	18.0%	10.8%	+25.6%	0.07%
ZOTA	₹4,139 cr	–	6.0x	-22.5%	-12.4%	-0.5%	+56.7%	0.07%
AIMTRON	₹3,319 cr	71.7x	17.1x	28.0%	31.8%	21.8%	–	–
ACCORD	₹2,984 cr	–	261.7x	12.4%	12.0%	2.4%	–	–
MONOLITH	₹2,646 cr	64.6x	24.3x	36.0%	48.7%	24.4%	–	–
UTSSAV	₹2,390 cr	40.2x	14.1x	43.4%	54.7%	7.9%	–	–
BETA	₹2,200 cr	40.6x	5.0x	16.4%	17.0%	20.8%	–	–
INFINIUM	₹443 cr	36.5x	4.2x	12.2%	19.6%	11.4%	–	–

All 688 companies in Other →

Documents

Links go to the original files on the exchange website.

About the company


Sector
Industry	Other
Sub-industry
Symbol	INFINIUM
BSE code	–
ISIN	INE0MRE01011
Face value	₹10.0
Incorporated	–
Website	–
Plants (India / abroad)	–

Data built 2026-10-23 from NSE company filings (XBRL: Integrated Filing - Financials + financial results); price = NSE close 2026-10-26.